-
-
-
-
-
-
-
Morgan Stanley Downgrades MapLight Therapeutics (MPLT) to Equalweight
-
-
-
-
-
-
-
Stifel on MapLight Therapeutics (MPLT): 'The last point will likely be the pushback on the data'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on MapLight Therapeutics (MPLT)
-
-
-
-
-
-
-
Stifel stays Buy rated on MapLight Therapeutics (MPLT) after in-line Q4 update
-
-
-
-
-
-
-
Morgan Stanley Starts MapLight Therapeutics (MPLT) at Overweight
-
-
-
-
456,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

